What is the success rate of stem cell therapy for Lupus (SLE)?
No pooled success rate applies across MSCs, HSCT and engineered immune cells. Review disease severity, organ involvement, background therapy, comparator, validated activity and damage indices, steroid reduction, relapse, serious infection, mortality and follow-up.
What the evidence shows for Lupus (SLE)
Standard care is tailored to organ involvement and may include antimalarial, immunosuppressive, biologic and supportive treatment. HSCT and newer cellular immune approaches have been studied mainly in selected severe or refractory disease and can involve substantial toxicity. MSC evidence remains investigational and heterogeneous. The NIAMS lupus treatment guide should be used to compare established care; evidence from one cellular platform cannot validate another.
Am I a candidate? → · Lupus (SLE): full overview → · Lupus (SLE) cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.